Factors Affecting Adherence to Anti-HIV Drug Regimens in Children and Adolescents
Cognitive, Behavioral, and Psychosocial Correlates of Medication Adherence in Children and Adolescents With HIV-1 Infection
2 other identifiers
observational
200
2 countries
36
Brief Summary
Taking anti-HIV medication consistently and properly is a critical issue for patients with HIV. Drug regimens are complex; when regimens are not taken properly, HIV can become resistant to the drugs. Taking anti-HIV medication properly leads to improved health. Children and adolescents with HIV face unique challenges to taking HIV medication properly. This study will look at the relationship between how children cope with the responsibility for taking medication and the child's language, memory, attention, behavior, and academic skills. This study is open to children and adolescents who are currently enrolled in the PACTG 219C study (Long-Term Effects of HIV Exposure and Infection in Children).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2004
Typical duration for all trials
36 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 20, 2003
CompletedFirst Posted
Study publicly available on registry
November 21, 2003
CompletedStudy Start
First participant enrolled
January 1, 2004
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2006
CompletedJune 3, 2013
May 1, 2013
November 20, 2003
May 31, 2013
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- HIV-1 perinatal infection
- Already enrolled and in active follow-up in PACTG 219C
- Can communicate in English or Spanish
- On antiretroviral medication regimen at the time of enrollment, regardless of compliance with regimen, with no planned treatment interruptions
You may not qualify if:
- Acquired HIV via routes other than perinatal transmission or source of HIV infection is unknown
- HIV-2 infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (36)
UAB, Dept. of Ped., Div. of Infectious Diseases
Birmingham, Alabama, 35233, United States
Phoenix Children's Hosp.
Phoenix, Arizona, 85006, United States
Long Beach Memorial Med. Ctr., Miller Children's Hosp.
Long Beach, California, 90801, United States
Usc La Nichd Crs
Los Angeles, California, 90033, United States
Children's Hosp. & Research Ctr. Oakland, Ped. Clinical Research Ctr. & Research Lab.
Oakland, California, 94609-1809, United States
UCSD Mother-Child-Adolescent Program CRS
San Diego, California, 92103, United States
UCSF Pediatric AIDS CRS
San Francisco, California, 94143-0105, United States
Univ. of Colorado Denver NICHD CRS
Denver, Colorado, 80218-1088, United States
Yale Univ. School of Medicine - Dept. of Peds., Div. of Infectious Disease
New Haven, Connecticut, 06504, United States
Children's National Med. Ctr., ACTU
Washington D.C., District of Columbia, 20010, United States
Howard Univ. Washington DC NICHD CRS
Washington D.C., District of Columbia, 20060, United States
South Florida CDTC Ft Lauderdale NICHD CRS
Fort Lauderdale, Florida, 33316, United States
Univ. of Miami Ped. Perinatal HIV/AIDS CRS
Miami, Florida, 33136, United States
Med. College of Georgia School of Medicine, Dept. of Peds., Div. of Infectious Diseases
Augusta, Georgia, 30912, United States
Chicago Children's CRS
Chicago, Illinois, 60614, United States
Tulane/LSU Maternal/Child CRS
New Orleans, Louisiana, 70112-2699, United States
Univ. of Maryland Med. Ctr., Div. of Ped. Immunology & Rheumatology
Baltimore, Maryland, 21201, United States
Johns Hopkins Hosp. & Health System - Dept. of Peds., Div. of Infectious Diseases
Baltimore, Maryland, United States
HMS - Children's Hosp. Boston, Div. of Infectious Diseases
Boston, Massachusetts, 02115, United States
Baystate Medical Center, Springfield
Springfield, Massachusetts, 01199, United States
NJ Med. School CRS
Newark, New Jersey, 07101-1709, United States
SUNY Downstate Med. Ctr., Children's Hosp. at Downstate NICHD CRS
Brooklyn, New York, 11203-2098, United States
Nyu Ny Nichd Crs
New York, New York, 10016, United States
Harlem Hosp. Ctr. NY NICHD CRS
New York, New York, 10037, United States
SUNY Stony Brook NICHD CRS
Stony Brook, New York, 11794-8111, United States
SUNY Upstate Med. Univ., Dept. of Peds.
Syracuse, New York, 13210, United States
Bronx-Lebanon Hosp. IMPAACT CRS
The Bronx, New York, 10457, United States
Jacobi Med. Ctr.
The Bronx, New York, 10461, United States
UNC at Chapel Hill School of Medicine - Dept. of Peds., Div. of Immunology & Infectious Diseases
Chapel Hill, North Carolina, 27599-7220, United States
DUMC Ped. CRS
Durham, North Carolina, 27705, United States
The Children's Hosp. of Philadelphia IMPAACT CRS
Philadelphia, Pennsylvania, 19104-4318, United States
St. Christopher's Hosp. for Children
Philadelphia, Pennsylvania, 19134, United States
St. Jude/UTHSC CRS
Memphis, Tennessee, 38105-2794, United States
Texas Children's Hosp. CRS
Houston, Texas, 77030, United States
Univ. of Puerto Rico Ped. HIV/AIDS Research Program CRS
San Juan, 00936-5067, Puerto Rico
San Juan City Hosp. PR NICHD CRS
San Juan, Puerto Rico
Related Publications (6)
Catz SL, Kelly JA, Bogart LM, Benotsch EG, McAuliffe TL. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol. 2000 Mar;19(2):124-33.
PMID: 10762096BACKGROUNDGordillo V, del Amo J, Soriano V, Gonzalez-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS. 1999 Sep 10;13(13):1763-9. doi: 10.1097/00002030-199909100-00021.
PMID: 10509579BACKGROUNDRogers AS, Miller S, Murphy DA, Tanney M, Fortune T. The TREAT (Therapeutic Regimens Enhancing Adherence in Teens) program: theory and preliminary results. J Adolesc Health. 2001 Sep;29(3 Suppl):30-8. doi: 10.1016/s1054-139x(01)00289-0. No abstract available.
PMID: 11530301BACKGROUNDGaughan DM, Hughes MD, Oleske JM, Malee K, Gore CA, Nachman S; Pediatric AIDS Clinical Trials Group 219C Team. Psychiatric hospitalizations among children and youths with human immunodeficiency virus infection. Pediatrics. 2004 Jun;113(6):e544-51. doi: 10.1542/peds.113.6.e544.
PMID: 15173535BACKGROUNDFarley JJ, Montepiedra G, Storm D, Sirois PA, Malee K, Garvie P, Kammerer B, Naar-King S, Nichols S; PACTG P1042S Team. Assessment of adherence to antiretroviral therapy in perinatally HIV-infected children and youth using self-report measures and pill count. J Dev Behav Pediatr. 2008 Oct;29(5):377-84. doi: 10.1097/DBP.0b013e3181856d22.
PMID: 18714204RESULTNaar-King S, Montepiedra G, Nichols S, Farley J, Garvie PA, Kammerer B, Malee K, Sirois PA, Storm D; PACTG P1042S Team. Allocation of family responsibility for illness management in pediatric HIV. J Pediatr Psychol. 2009 Mar;34(2):187-94. doi: 10.1093/jpepsy/jsn065. Epub 2008 Jun 27.
PMID: 18586756RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Sharon Nichols, PhD
Department of Neurosciences, University of California, San Diego
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 20, 2003
First Posted
November 21, 2003
Study Start
January 1, 2004
Study Completion
October 1, 2006
Last Updated
June 3, 2013
Record last verified: 2013-05